标普和纳斯达克内在价值 联系我们

NeuroOne Medical Technologies Corporation NMTC NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+300%

NeuroOne Medical Technologies Corporation (NMTC) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Devices 行业. 公司总部位于 Eden Prairie, MN, 美国. 现任CEO为 David A. Rosa.

NMTC 拥有 IPO日期为 2018-03-15, 17 名全职员工, 在 NASDAQ Capital Marke, 市值为 $38.02M.

关于 NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

📍 7599 Anagram Drive, Eden Prairie, MN 55344 📞 952 426 1383
公司详情
所属板块医疗保健
细分行业Medical - Devices
国家美国
交易所NASDAQ Capital Marke
货币USD
IPO日期2018-03-15
首席执行官David A. Rosa
员工数17
交易信息
当前价格$0.75
市值$38.02M
52周区间0.395-1.16
Beta0.58
ETF
ADR
CUSIP64130M209
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言